|
|
|
41
|
5281BV
|
APROCIN 0.3% EYE DR (ARP) CIPROFLOXACIN (BH)
|
CIPROFLOXACIN
|
APROCIN
|
10ML
|
BH
|
8.15
|
8.15
|
BOTT
|
0
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTIBACTERIALS
|
|
|
|
|
41
|
5281BW
|
FUSITHAL 1% EYE DR (ARP) FUSIDIC ACID
|
FUSIDIC ACID
|
FUSITHAL
|
5G
|
A
|
10.57
|
10.5743
|
TUBE
|
1
|
BOX
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5281BW
|
FUSITHAL 1% EYE DR (ARP) FUSIDIC ACID
|
FUSIDIC ACID
|
FUSITHAL
|
5G
|
A
|
10.57
|
10.57
|
TUBE
|
1
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
40
|
5281BX
|
OPTIMOX 0.5% EYE DR (ARP/AHI) MOXIFLOXACIN
|
MOXIFLOXACIN
|
OPTIMOX
|
5ML
|
BQ
|
8.70
|
8.70
|
EYE DROP
|
0
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
5281BY
|
T-MYCIN 0.3% EYE DR (ARP) TOBRAMYCI (BH)
|
TOBRAMYCIN
|
T-MYCIN
|
5ML
|
BH
|
5.44
|
5.4366
|
BOTT
|
2
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTIBACTERIALS
|
|
|
|
|
40
|
5281CB
|
TOBREX 0.3% EYE DR (NVS/COL) TOBRAMYCIN
|
TOBRAMYCIN
|
TOBREX
|
5ML
|
C
|
23.30
|
23.30
|
EYE DROP
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
5281CB
|
TOBREX 0.3% EYE DR (NVS) TOBRAMYCIN (C)
|
TOBRAMYCIN
|
TOBREX
|
5ML
|
C
|
16.31
|
16.3099
|
BOTT
|
2
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTIBACTERIALS
|
|
|
|
|
40
|
5281CC
|
APO-GATIFLOXACIN 0.3% EYE DR (APO/COL)
|
GATIFLOXACIN
|
APO-GATIFLOXACIN
|
5ML
|
BQ
|
9.51
|
9.51
|
EYE DROP
|
1
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
5281CD
|
VIGAMOX 0.5% EYE DR (NVS/COL) MOXIFLOXACIN
|
MOXIFLOXACIN
|
VIGAMOX
|
3ML
|
C
|
27.05
|
27.05
|
EYE DROP
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
5281CE
|
VIGAMOX 0.5% EYE DR (NVS) MOXIFLOXACIN (C)
|
MOXIFLOXACIN
|
VIGAMOX
|
5ML
|
C
|
45.4
|
45.396
|
BOTT
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5281CE
|
VIGAMOX 0.5% EYE DR (NVS) MOXIFLOXACIN
|
MOXIFLOXACIN
|
VIGAMOX
|
5ML
|
C
|
45.40
|
45.40
|
BOTT
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
41
|
5281CF
|
ENMOX 0.5% EYE DR (SHC) MOXIFLOXACIN (BQ)
|
MOXIFLOXACIN
|
ENMOX
|
5ML
|
BQ
|
5.71
|
5.7085
|
BOTT
|
0
|
BOTT
|
SHC
|
SION HEALTHCARE
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5281CR
|
4QUIN 0.5% EYE DR (ADO) MOXIFLOXACIN
|
MOXIFLOXACIN
|
4 QUIN
|
5ML
|
BQ
|
6.25
|
6.25
|
BOTT
|
0
|
BOTT
|
ADO
|
ADORE PHARMA
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5281CS
|
TOBRACID 0.3% EYE DR (SHC) TOBRAMYCIN
|
TOBRAMYCIN
|
TOBRACID
|
5ML
|
C
|
2.77
|
2.77
|
BOTT
|
2
|
BOTT
|
SHC
|
SION HEALTHCARE
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTIBACTERIALS
|
|
|
|
|
40
|
5281P
|
GOTABIOTIC 0.3% EYE DR (LPO/COL) TOBRAMY
|
TOBRAMYCIN
|
GOTABIOTIC
|
5ML
|
BH
|
7.34
|
7.34
|
EYE DROP
|
0
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
Ophthalmic
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
5281P
|
GOTABIOTIC 0.3% EYE DR (LPO) TOBRAMYCIN (BH)
|
TOBRAMYCIN
|
GOTABIOTIC
|
5ML
|
BH
|
7.42
|
7.421
|
BOTT
|
2
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5281P
|
GOTABIOTIC 0.3% EYE DR (LPO) TOBRAMYCIN
|
TOBRAMYCIN
|
GOTABIOTIC
|
5ML
|
C
|
13.59
|
13.59
|
BOTT
|
2
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
AVENTA BARBADOS
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTIBACTERIALS
|
|
|
|
|
41
|
5282E
|
APROCIN 0.3% OINT (ARP) CIPROFLOXAC (BH)
|
CIPROFLOXACIN
|
APROCIN
|
3G
|
BH
|
2.64
|
2.6368
|
TUBE
|
0
|
BOX
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5282E
|
APROCIN 0.3% OINT (ARP) CIPROFLOXAC
|
CIPROFLOXACIN
|
APROCIN
|
3G
|
BH
|
2.72
|
2.72
|
TUBE
|
0
|
BOX
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
40
|
5282F
|
T-MYCIN 0.3% OINT (ARP/AHI) TOBRAMYCIN
|
TOBRAMYCIN
|
T-MYCIN
|
3G
|
BH
|
10.00
|
10.00
|
OINT
|
0
|
TUBE
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2022-09-30
|
|
TOPICAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-03-29
|